Projects & Grants

Projects and Grants per year 2021 2021 2024 2030

• 1 Finished
• 2 Active

Projects and Grants per year

Search results

• Active

  Rapcabtagene: A Phase 2, Adaptive, Randomized, Open-Label, Assessor-Blinded Active-Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel vs. SOC in Patients Suffering from Systemic Lupus Erythematosus (SLE) with Active, Refractor

  Piranavan, P. (PI), Ahmed, S. (CoI), Alkilany, R. (CoI) & Qasrawi, A. (CoI)

  Novartis (domestic)

  11/8/24 → 12/21/30

  Project: Research project

• A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Proliferative Lupus Nephritis or Immunoglobulin A Nephropathy

  Ahmed, S. (PI)

  Syneos Health LLC

  7/1/21 → 1/29/26

  Project: Research project

• Finished

  A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants Who Have Thrombotic Microangiopathy Associated With a Trigger

  Ahmed, S. (PI)

  Alexion Pharmaceuticals

  7/31/21 → 5/2/23

  Project: Research project